Ayrton Capital SC 13G/A CEMTREX / Ayrton Capital ownership change

Exhibit 1

Joint Filing Statement

Statement Pursuant to Rule 13d-1(k)(1)

The undersigned hereby consent and agree to file a joint statement on Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock, $0.001 Par Value, of Intersect ENT, Inc., beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent and agree to file this Statement pursuant to Rule 13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule 13G.

Dated:June 9, 2020	Ayrton Capital LLC
	By:	/s/ Waqas Khatri
	Name:	Waqas Khatri
	Title:	Managing Member
	Alto Opportunity Master Fund SPC – Segregated Master Portfolio B
	By:	/s/ Waqas Khatri
	Name:	Waqas Khatri
	Title:	Managing Member
	Ayrton Capital LLC
	By:	Waqas Khatri
	By:	/s/ Waqas Khatri
	Name:	Waqas Khatri
	Title:	Managing Member